Vivex Biomedical's Series A - II Round

Vivex Biomedical raised a round of funding on January 05, 2016.

Vivex Biomedical is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage I…

Articles about Vivex Biomedical's Series A - II Round: